| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $130.9M | — | +12.9% |
| R&D Expense | $28.3M | — | -11.0% |
| SG&A Expense | $18.4M | — | +11.9% |
| Operating Income | $6.7M | — | +305.3% |
| Pre-tax Income | $4.7M | — | +248.6% |
| Income Tax | $1.8M | — | +139.5% |
| Net Income | $3.0M | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $89.6M | -8.1% | +19.3% |
| Current Assets | $267.3M | -4.5% | +24.1% |
| Total Assets | $666.1M | +0.4% | +66.4% |
| Current Liabilities | $152.1M | -17.0% | +37.4% |
| Long-term Debt | $612K | -77.0% | -62.4% |
| Total Liabilities |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $23.9M | — | +61.1% |
| Capital Expenditures | $4.3M | — | +23.0% |
| Investing Cash Flow | $4.8M | — | +165.0% |
| Financing Cash Flow | -$26.1M | — | -3013.7% |
| Free Cash Flow | $19.6M | — | +72.9% |
| +175.7% |
| EPS (Basic) | $0.05 | — | +171.4% |
| EPS (Diluted) | $0.05 | — | +171.4% |
| $307.1M |
| -6.0% |
| +159.8% |
| Stockholders' Equity | $359.1M | +6.5% | +27.3% |